Midday Stock Movements: Notable Gains and Losses
- Lockheed Martin and CACI International report notable gains after upgrades.
- JetBlue Airways experiences a sharp decline amid restructuring news.
- Surgery Partners surges 47% following a substantial buyout agreement.
Several companies are making significant moves in midday trading. Lockheed Martin, the defense contractor, rose by 3% after receiving an upgrade from Morgan Stanley, which increased its 12-month price target to $835 from $690, indicating a potential 38% upside from the previous close. CACI International also saw a 6% increase after Jefferies upgraded its rating to buy, with a new price target of $725, suggesting nearly 17% upside from last week’s close.
In contrast, JetBlue Airways, based in New York, fell by 12% after a Wall Street Journal report revealed that senior creditors are collaborating with a restructuring advisor. This news follows a significant drop in the company’s bond prices and a decline of approximately 50% in its stock price year-to-date.
Verizon Communications experienced a 3% decline in its shares following the release of its third-quarter earnings report. Meanwhile, Xencor’s stock surged by 20% to a 52-week high of $30 after the biotech firm announced positive results for its therapy targeting advanced clear cell renal cell carcinoma, stating that its existing cash reserves would support research and operations through 2029.
Shares of companies in the neocloud sector increased after Elon Musk posted on X regarding impending changes; CoreWeave and Iren each gained 5%, while Nebius rose by 1%. Tesla also climbed by 6% after Barclays upgraded its rating to overweight, citing a potential merger opportunity with SpaceX and growth prospects in its Robotaxi business.
Range Resources saw a significant increase of 15% after EQT Corp announced plans to acquire the company in an all-stock deal valued at over $50 billion, expected to close in the first quarter of 2027. Conversely, Moderna’s shares fell another 2% following an 18% drop over the prior Thursday and Friday due to concerns arising from a leaked cancer vaccine study.
Booz Allen Hamilton experienced an 8% rally after being upgraded to buy with a $95 price target by TD Cowen, attributed to improved metrics. Ross Stores added 3% following an upgrade from UBS, with analysts projecting that enhanced store productivity could boost the stock above $300.
Surgery Partners’ stock surged by 47% after Bon Secours Mercy Health announced a buyout at $23.50 per share, equating to $5.7 billion. In contrast, Fair Isaac saw a 14% drop after Wells Fargo downgraded its rating, with analysts citing a refusal to raise prices to ensure lenders continued using its FICO scores.
Maplebear, the parent company of delivery service Instacart, fell nearly 6% after reports indicated it is exploring a potential sale, including early-stage discussions with DoorDash and Uber.
News Courtesy of CNBC
